These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1405215)

  • 21. [Use of dalargin in the treatment of acute cholecystopancreatitis complicated by obstructive jaundice].
    Skomarovskiĭ ATs; Zemskov VS; Skomarovskiĭ AA
    Klin Khir; 1996; (8):13-4. PubMed ID: 9064131
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of dalargin on the hemodynamics in acute myocardial infarct complicated by clinical death].
    Lisachenko GV; Slepushkin VD; Zoloev GK
    Anesteziol Reanimatol; 1992; (4):57-9. PubMed ID: 1485679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Participation of central and peripheral mu- and delta opiate receptors in anti-arrhythmia action of enkephalins].
    Maslov LN; Lishmanov IuB
    Biull Eksp Biol Med; 1991 Aug; 112(8):124-6. PubMed ID: 1664748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prophylaxis of pancreatogenic disturbances by infusion of monomer-electrolyte solutions combined with dalargin].
    Koval'skaia KS; Emel'ianov SI
    Biull Eksp Biol Med; 1998 Oct; 126(10):401-4. PubMed ID: 9825135
    [No Abstract]   [Full Text] [Related]  

  • 25. Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure.
    Ciriello J; Caverson MM; McMurray JC; Bruckschwaiger EB
    Neuroscience; 2013 Oct; 250():599-613. PubMed ID: 23912034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The dynamic cytochemical properties of the protective barrier of the stomach during dalargin administration].
    Mogil'naia GM; Korot'ko GF; Kurzanov AN
    Morfologiia; 1996; 109(3):72-5. PubMed ID: 8983489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of dalargin on the content of endorphins, leucine-enkephalin ACTH and corticosterone of the blood of stressed rats].
    Bobkov AI; Polonskiĭ VM; Vinogradov VA; Demina DG; Smagin VG
    Biull Eksp Biol Med; 1985 Dec; 100(12):715-7. PubMed ID: 3000473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bradycardia in a Child After Using Brimonidine as Toothpaste.
    Montague AJ; Bangh S; Cole JB
    JAMA Dermatol; 2017 Apr; 153(4):330-331. PubMed ID: 28297016
    [No Abstract]   [Full Text] [Related]  

  • 29. [Restriction of functional disorders by the use of a regulatory peptide dalargin in burned rats infected with Staphylococcus aureus].
    Pashutin SB
    Biull Eksp Biol Med; 1990 Jul; 110(7):24-6. PubMed ID: 2224089
    [No Abstract]   [Full Text] [Related]  

  • 30. [1st experiment in the clinical use of the Soviet synthetic peptide, dalargin in patients with ischemic heart disease].
    Samarenko MB; Karpov IuA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):96-8. PubMed ID: 6639766
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bioavailability of dalargin and its metabolism during intranasal administration to rats].
    Vinogradov VA; Kalenikova EI; Sokolov AS
    Biull Eksp Biol Med; 1988 Jul; 106(7):48-50. PubMed ID: 3401577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of the synthetic leu-enkephalin analog dalargin on liver metabolism and blood supply in acute blood loss in rats].
    Zoloev GK; Kovalenko NIa; Matsievskiĭ DD
    Patol Fiziol Eksp Ter; 1988; (3):48-52. PubMed ID: 3174252
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of a synthetic opioid for the reversal of stress-induced damage of the myocardium and gastric mucosa in severe thermal trauma].
    Dvortsin GF
    Kardiologiia; 1989 Sep; 29(9):81-3. PubMed ID: 2593479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The efficacy of using dalargin electrophoresis in the combined treatment of patients with ischemic heart disease].
    Ilaev TM; Ratner ZG
    Lik Sprava; 1998; (2):74-7. PubMed ID: 9670662
    [No Abstract]   [Full Text] [Related]  

  • 35. [The reinfusion of blood and the administration of dalargin in experimental hemorrhagic shock].
    Sherman DM; Trach VM
    Klin Khir (1962); 1994; (9):38-41. PubMed ID: 7602944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dalargin--a peptide preparation with cytoprotective action].
    Titov MI; Vinogradov VA; Bespalova ZhD
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(2):72-6. PubMed ID: 2998416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of thymogen on the heart in ischemia and reperfusion].
    Filippova OV; Reznikov KM; Alabovskił VV; Khamburov VV; Vinokurov AA
    Eksp Klin Farmakol; 1997; 60(3):27-9. PubMed ID: 9324392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness of the use of synthetic opioid peptide in rats with traumatic shock].
    Mikhaĭlova NN; Slepushkin VD
    Patol Fiziol Eksp Ter; 1995; (4):27-9. PubMed ID: 8700589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can the extent of heart rate reduction predict the clinical response of infantile haemangiomas to propranolol?
    Chong JH; Prey S; Mya HT; Delarue A; Labreze C
    Br J Dermatol; 2018 Mar; 178(3):e196-e197. PubMed ID: 28886210
    [No Abstract]   [Full Text] [Related]  

  • 40. [The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].
    Bazhanov NN; Ganina SS; Pashutin SB; Ragimov ChR
    Sov Med; 1991; (7):29-31. PubMed ID: 1948337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.